Eurofins-Cerep SA (EPA:ALECR)

Market Cap	92.81M +4.0%
Revenue (ttm)	41.10M +1.5%
Net Income	4.78M -33.2%
EPS	n/a
Shares Out	5.04K
PE Ratio	19.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	18,400
Day's Range	n/a
52-Week Range	15,000 - 18,600
Beta	0.11
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Eurofins-Cerep

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 197
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALECR

Financial Performance

In 2025, Eurofins-Cerep's revenue was 41.10 million, an increase of 1.51% compared to the previous year's 40.49 million. Earnings were 4.78 million, a decrease of -33.15%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 22, 2026

Data Sources Report a data error